Article

Cataracts and AMD may be prevented by exercise, according to study

Vigorous exercise may help prevent age-related macular degeneration and cataracts, according to a new study.

Washington, DC-Vigorous exercise may help prevent age-related macular degeneration (AMD) and cataracts, according to a new study.

In one group of data from almost 8 years of follow-up from the National Runners’ Health Study, 110 men and 42 women received a clinical diagnosis of AMD during follow-up. The higher the frequency of running, the less risk participants had for developing AMD.

On average, running 2 to 4 km (1.2 to 2.5 miles) a day reduced the risk by 19% and running more than 4 km a day reduced the risk by 42% to 54%, compared with those who ran less than 2 km a day.

In the same group, a study examining the effects of running on developing cataracts, 733 men and 179 women reported having cataracts during the follow-up. Running 64 or more km (40 miles) a week lowered the risk by 35%, compared with those who ran less than 16 km (10 miles) per week. Those with better cardiovascular fitness were also at less risk than men who were less fit.

It is not fully known why a link exists between fitness and preventing these conditions, however, study author Paul T. Williams, a staff scientist with the U.S. Department of Energy’s Lawrence Berkeley National Laboratory, said that exercise could provide similar protective benefits for the eyes as it does for the heart and other systems.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.